Skip to main content
Brandon Huffman, MD, Oncology, Boston, MA, Brigham and Women's Hospital

BrandonMichaelHuffmanMD

Oncology Boston, MA

Gastrointestinal Cancer

Medical Oncologist

Dr. Huffman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Huffman's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2020 - 2023
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Chief Residency, Internal Medicine, 2019 - 2020
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2015 - 2018
  • University of Missouri-Columbia School of Medicine
    University of Missouri-Columbia School of MedicineClass of 2015

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2020 - 2024
  • MN State Medical License
    MN State Medical License 2016 - 2020
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Validation of lymphocyte to monocyte ratio in resected small bowel adenocarcinoma as a predictor of survival. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Zentalis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Updates
    Zentalis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational UpdatesNovember 9th, 2022
  • Natera Releases New Clinical Data at ESMO 2021 in Gastroesophageal Cancer and Uveal Melanoma
    Natera Releases New Clinical Data at ESMO 2021 in Gastroesophageal Cancer and Uveal MelanomaSeptember 17th, 2021

Professional Memberships

Hospital Affiliations